2022 · BIOMEDICINES

Questions about Residual Cell Viability in Cryopreserved Human Amniotic Membrane and Its Impact on Clinical Applications

Gaudet, Camille, Solecki, Lauriana, Matheaud, Bastien, Odet, Stephane, Meyer, Christophe, Louvrier, Aurelien, Gindraux, Florelle

Journal
BIOMEDICINES
Année
2022
Volume
10
Numéro
10
Article
2456
Mois
OCT
DOI
10.3390/biomedicines10102456

Abstract

We questioned the relevance of evaluating residual cell viability in human amniotic membrane (hAM) after its cryopreservation since cell survival is controversial and its ability to act as a matrix (including the presence of growth factors and cytokines) appears to be most important for tissue regeneration purposes. We also discussed the usefulness of osteodifferentiating amniotic cells in whole hAM for bone repair applications. We have evidence that determining residual cell viability after cryopreservation and hAM osteodifferentiation is not justified.

Lire l'article complet